1. Gut Microbiota Dysbiosis Associated with Bile Acid Metabolism in Neonatal Cholestasis Disease
- Author
-
Ming-Ying Wang, Chuanfa Liu, Si-Xiang Liu, Hongwei Hu, Yongkun Huang, Jianwen Yin, and Meng Li
- Subjects
0301 basic medicine ,lcsh:Medicine ,Gut flora ,Lactobacillus gasseri ,medicine.disease_cause ,Article ,Microbiology ,Bile Acids and Salts ,03 medical and health sciences ,Feces ,0302 clinical medicine ,Liver Function Tests ,medicine ,Humans ,Streptococcus gallolyticus ,Neonatal cholestasis ,lcsh:Science ,Multidisciplinary ,Cholestasis ,biology ,business.industry ,lcsh:R ,Infant, Newborn ,Infant ,Diagnostic markers ,biology.organism_classification ,medicine.disease ,Prognosis ,Gastrointestinal Microbiome ,030104 developmental biology ,Liver ,030220 oncology & carcinogenesis ,Parabacteroides distasonis ,Dysbiosis ,Metagenome ,lcsh:Q ,Liver function ,Disease Susceptibility ,Metagenomics ,business ,Biomarkers - Abstract
Neonatal cholestasis disease (NCD) is a complex and easily mis-diagnosed condition. We analyzed microbiota community structure in feces and measured short-chain fatty acids, bile acids (BAs) and liver function of 12 healthy, 13 NCD, and 13 treated infants after diagnosis. Based on 16S rRNA gene amplicon sequencing and gas-chromatographic-mass-spectrometric analysis of secondary BAs, we identified microbial genera and metabolites that associate with abnormal bile secretion. Streptococcus gallolyticus and Parabacteroides distasonis, and Lactobacillus gasseri had higher relative abundance in healthy and NCD infants respectively. Compared to NCD patients, healthy infants had higher LCA, CDCA and GCDCA fecal concentrations. The three microbial species and three secondary bile acids were selected as potential non-invasive combined biomarkers to diagnose NCD. We propose that microbiota-metabolite combined biomarkers could be used for diagnosis of NCD, and this may contribute to improved early clinical diagnosis of NCD in the future.
- Published
- 2020